HappeningToo topic
Secukinumab reports
Browse community reports connected to Secukinumab. These reports can show that other people are describing similar experiences, but they do not prove that Secukinumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
25 problems
Abdominal Discomfort while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and abdominal discomfort appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and abdominal pain upper appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and alopecia appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and anxiety appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and back pain appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and cough appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and decreased appetite appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and diarrhea appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and dizziness appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and fatigue appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and headache appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and hives appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and insomnia appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and itching appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and malaise appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and nausea appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and pain appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and rash appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and shortness of breath appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Skin redness while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and skin redness appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and swelling appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and vomiting appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and weakness appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and weight decreased appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Secukinumab
FDA FAERS contains adverse-event reports in which Secukinumab and weight increased appear together. This does not establish that Secukinumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →